Fabry's disease discovered with chance urinary mulberry cells: a case report

被引:0
作者
Nakamichi, Takashi [1 ]
Miyazaki, Mariko [1 ]
Nakayama, Keisuke [1 ]
Sato, Mitsuhiro [2 ]
Akiu, Naoki [3 ]
Sato, Toshinobu [2 ]
Sato, Hiroshi [1 ]
Ito, Sadayoshi [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Sendai Shakaihoken Hosp, Dept Nephrol, Aoba Ku, Sendai, Miyagi 9818501, Japan
[3] Sendai City Hosp, Dept Internal Med, Wakabayashi Ku, Sendai, Miyagi 9840075, Japan
关键词
Fabry's disease; Enzyme replacement therapy; Mulberry cell;
D O I
10.1007/s13730-012-0038-x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Fabry's disease (FD) is a rare X-linked lysosomal storage disorder. Novel enzyme replacement therapy (ERT) at an early stage can slow the progression of cardiovascular and renal dysfunction. Urinary mulberry cells are occasionally found in renal FD. We report a case of variant FD in which detection of urinary mulberry cells led to an early diagnosis. A 36-year-old Japanese man was referred to our hospital because mulberry cells had been detected during urinalysis. Proteinuria and renal dysfunction were not observed. His plasma alpha-galactosidase activity was very low. Renal biopsy revealed typical foamy changes in the glomerular podocytes and tubular epithelial cells that are found in renal FD. Based on the detection of urinary mulberry cells, we successfully started ERT before the patient's renal function deteriorated. Clinical nephrologists and laboratory technicians should recognize the importance of screening for mulberry cells during urinalysis as this is a simple, inexpensive, and non-invasive method for diagnosing FD.
引用
收藏
页码:49 / 52
页数:4
相关论文
共 16 条
[1]   Safety and efficacy of recombinant human α-galactosidase a replacement therapy in Fabry's disease. [J].
Eng, CM ;
Guffon, N ;
Wilcox, WR ;
Germain, DP ;
Lee, P ;
Waldek, S ;
Caplan, L ;
Linthorst, GE ;
Desnick, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (01) :9-16
[2]   Prevalence and Cardiovascular Features of Japanese Hemodialysis Patients with Fabry Disease [J].
Fujii, Hideki ;
Kono, Keiji ;
Goto, Shunsuke ;
Onishi, Tetsuari ;
Kawai, Hiroya ;
Hirata, Ken-ichi ;
Hattori, Kiyoko ;
Nakamura, Kimitoshi ;
Endo, Fumio ;
Fukagawa, Masafumi .
AMERICAN JOURNAL OF NEPHROLOGY, 2009, 30 (06) :527-535
[3]   Significance of screening for Fabry disease among male dialysis patients [J].
Ichinose M. ;
Nakayama M. ;
Ohashi T. ;
Utsunomiya Y. ;
Kobayashi M. ;
Eto Y. .
Clinical and Experimental Nephrology, 2005, 9 (3) :228-232
[4]  
Kudo S, 2007, IGAKU KENSA, V56, P875
[5]   Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data [J].
Mehta, A. ;
Beck, M. ;
Elliott, P. ;
Giugliani, R. ;
Linhart, A. ;
Sunder-Plassmann, G. ;
Schiffmann, R. ;
Barbey, F. ;
Ries, M. ;
Clarke, J. T. R. .
LANCET, 2009, 374 (9706) :1986-1996
[6]   Prevalence of lysosomal storage disorders [J].
Meikle, PJ ;
Hopwood, JJ ;
Clague, AE ;
Carey, WF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (03) :249-254
[7]  
Mitsuhashi F, 2003, J NIPPON MED SCH, V70, P583
[8]   AN ATYPICAL VARIANT OF FABRYS-DISEASE IN MEN WITH LEFT-VENTRICULAR HYPERTROPHY [J].
NAKAO, S ;
TAKENAKA, T ;
MAEDA, M ;
KODAMA, C ;
TANAKA, A ;
TAHARA, M ;
YOSHIDA, A ;
KURIYAMA, M ;
HAYASHIBE, H ;
SAKURABA, H ;
TANAKA, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (05) :288-293
[9]   RENAL PATHOLOGIC LESIONS AND FUNCTIONAL ALTERATIONS IN A MAN WITH FABRYS-DISEASE [J].
PABICO, RC ;
ATANACIO, BC ;
MCKENNA, BA ;
PAMUKCOGLU, T ;
YODAIKEN, R .
AMERICAN JOURNAL OF MEDICINE, 1973, 55 (03) :415-425
[10]  
Seino Yoshihiko, 2005, Journal of Nippon Medical School, V72, P254, DOI 10.1272/jnms.72.254